Updates are available Addendum dated 2023-06-13
Click to view Addendum: https://doi.org/10.1038/s41467-023-39141-w
-
Authors
Schmidt, Moritz J.
Gupta, Ashish
Bednarski, Christien
Gehrig-Giannini, Stefanie
Richter, Florian
Pitzler, Christian
Gamalinda, Michael
Galonska, Christina
Takeuchi, Ryo
Wang, Kui
Reiss, Caroline
Dehne, Kerstin
Lukason, Michael J.
Noma, Akiko
Park-Windhol, Cindy
Allocca, Mariacarmela
Kantardzhieva, Albena
Sane, Shailendra
Kosakowska, Karolina
Cafferty, Brian
Tebbe, Jan
Spencer, Sarah J.
Munzer, Scott
Cheng, Christopher J.
Scaria, Abraham
Scharenberg, Andrew M.
Cohnen, André https://orcid.org/0000-0001-9349-3331
Coco, Wayne M. https://orcid.org/0000-0003-2551-2291
- License Information
-
More Information
Article History
Received: 15 January 2021
Accepted: 14 June 2021
First Online: 9 July 2021
Competing interests
: A.C., M.J.S., W.M.C., M.G., A.G., C.P., F.R., J.T., C.J.C., R.T., C.W.R., K.W., K.K., A.K., A.S., A.N., S.S. have filed patent applications through Bayer AG, Casebia LLC, and CRISPR Therapeutics on the results described herein. A.C., W.M.C., M.G., K.K., A.G., M.L., S.J.S., C.P., M.S., J.T. hold stock or shares in the affiliated companies.
